Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 63%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT has significantly expanded its structured finance portfolio, increasing from $15 million in 2022 to $871 million, enhancing operator relationships and diversifying its yield. The company benefits from a strong market environment, with public REITs in its sector averaging 22% same-store net operating income (NOI) growth over the past two years and a favorable supply/demand outlook projected for the next five years. Additionally, portfolio optimization is nearing completion, positioning CareTrust REIT for incremental growth while tenant credit concerns have stabilized, allowing for more strategic capital deployment.

Bears say

CareTrust REIT faces a negative outlook primarily due to a projected decline in cash collections, estimated at approximately 5%, which could hinder overall revenue growth. Additionally, increasing competition in the property market may lead to rising property prices, negatively affecting profitability amidst tightening capital market conditions. Furthermore, the potential impact of legislative changes, such as the CA 525 bill, poses further risks to operators' profitability and, by extension, may pressure CareTrust REIT's rental income.

CareTrust REIT (CTRE) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 63% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 8 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Apr 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.